Cargando…
Toxoplasmosis in a patient receiving ixekizumab for psoriasis
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033296/ https://www.ncbi.nlm.nih.gov/pubmed/32149179 http://dx.doi.org/10.1016/j.jdcr.2020.01.005 |
_version_ | 1783499635547963392 |
---|---|
author | Lobo, Yolanka Holland, Teagan Spelman, Lynda |
author_facet | Lobo, Yolanka Holland, Teagan Spelman, Lynda |
author_sort | Lobo, Yolanka |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7033296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-70332962020-03-06 Toxoplasmosis in a patient receiving ixekizumab for psoriasis Lobo, Yolanka Holland, Teagan Spelman, Lynda JAAD Case Rep Case Report Elsevier 2020-02-19 /pmc/articles/PMC7033296/ /pubmed/32149179 http://dx.doi.org/10.1016/j.jdcr.2020.01.005 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Lobo, Yolanka Holland, Teagan Spelman, Lynda Toxoplasmosis in a patient receiving ixekizumab for psoriasis |
title | Toxoplasmosis in a patient receiving ixekizumab for psoriasis |
title_full | Toxoplasmosis in a patient receiving ixekizumab for psoriasis |
title_fullStr | Toxoplasmosis in a patient receiving ixekizumab for psoriasis |
title_full_unstemmed | Toxoplasmosis in a patient receiving ixekizumab for psoriasis |
title_short | Toxoplasmosis in a patient receiving ixekizumab for psoriasis |
title_sort | toxoplasmosis in a patient receiving ixekizumab for psoriasis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033296/ https://www.ncbi.nlm.nih.gov/pubmed/32149179 http://dx.doi.org/10.1016/j.jdcr.2020.01.005 |
work_keys_str_mv | AT loboyolanka toxoplasmosisinapatientreceivingixekizumabforpsoriasis AT hollandteagan toxoplasmosisinapatientreceivingixekizumabforpsoriasis AT spelmanlynda toxoplasmosisinapatientreceivingixekizumabforpsoriasis |